Biotech Innovator InstaMed® Pharmaceuticals Appoints Tracy Gibbs, PhD, as Chief Executive Officer Ahead of Worldwide Launch of Non-Injectable Peptide Platform

Oral dissolving peptide filmsPositive

AI Analysis

Summary

InstaMed Pharmaceuticals appoints Tracy Gibbs as CEO ahead of August 3 launch of five oral dissolving peptide films, supported by successful double-blinded pharmacokinetic study data and nine pending patents.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Product launch of five next-generation oral dissolving peptide films

Importance:5/10

Sentiment:

0.70

product launchpeptide platformoral dosage formCEO appointmentpharmacokinetic study

Related Companies

$GBIO

Read the original article

Published by PR Newswire Biotech on July 27, 2026 7:35 PM

Read Original